|
|
| Your ‘YES’ today could give people with Alzheimer’s and their families more memorable days. |
|
|
|
|
 |
Dear John,
We must act together now to have our voices heard.
More than six million Americans are estimated to have Alzheimer’s today, and everyone who has the disease will die of it or with it. There are no survivors. A treatment for Alzheimer’s disease has not been approved since 2003. Those treatments that are approved only improve symptoms, and only for some. Not one stops or slows progression of the disease.
That could, and should, soon change. The U.S. Food and Drug Administration (FDA) is currently reviewing aducanumab, a new treatment for Alzheimer’s. A clinical trial of aducanumab reported a 22% reduction in cognitive and functional decline compared to placebo.
It’s time for more time for those facing Alzheimer’s.
|
|
|
Patients facing terminal cancers and other fatal diseases have benefited from approvals of treatments that offer them and their families more time. Those facing Alzheimer’s deserve the same opportunity.
This treatment could add weeks, months or even years for individuals and families. Today, simply by clicking ‘YES’, you could help gain #MoreTime.
|
|
|
Sincerely,
Harry Johns
President/CEO
Alzheimer’s Association
P.S. Now is the time for #MoreTime. For more information visit, alz.org/moretime.
Disclosures
The author, who is an employee of the Alzheimer’s Association, has no individual disclosures. The Alzheimer’s Association received 0.89% of its total 2020 contributed revenue from the biotechnology, pharmaceutical, diagnostics and clinical research industry, including 0.15% from Biogen and Eisai. alz.org/transparency
|
|
|
|
|
